Related Experiment Video
Updated: Aug 2, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
Emerging Modalities for Temporary Mechanical Circulatory Support in Cardiogenic Shock
Ameesh Isath1, Tzvi Fishkin2, Yaakov Spira2
1From the Departments of Cardiology.
Cardiology in Review
|April 18, 2023
Summary
Cardiogenic shock (CS) requires prompt treatment. Temporary mechanical circulatory support (MCS) devices aid recovery by optimizing myocardial oxygen demand and supporting organ perfusion.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a critical condition demanding immediate medical intervention.
- Standardized criteria, like those from the Society for Cardiovascular Angiography and Interventions, aid in patient classification and treatment planning.
Purpose of the Study:
- To review temporary mechanical circulatory support (MCS) devices for cardiogenic shock.
- To discuss the mechanisms, benefits, and drawbacks of various MCS modalities.
Main Methods:
- Literature review of temporary mechanical circulatory support (MCS) devices.
- Analysis of device mechanisms, advantages, and disadvantages in treating cardiogenic shock.
Main Results:
- Mechanical circulatory support (MCS) offers a bridge to recovery or advanced therapies.
- Tailored, stepwise escalation of MCS support is crucial for end-organ perfusion and myocardial recovery.
- Newer MCS devices can reduce myocardial oxygen demand, enhancing recovery potential.
Conclusions:
- Mechanical circulatory support (MCS) is integral to managing cardiogenic shock.
- Individualized MCS strategies are key to optimizing patient outcomes.
- The choice of MCS device impacts myocardial recovery and overall prognosis.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
825
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
825
01:22Heart Failure VI: Adjunct Therapies
19
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
19
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
46
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
46
01:30Cardiomyopathy II: Dilated Cardiomyopathy
13
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13
01:30Heart Failure V: Medical Management
17
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
17
01:14Ventilatory Modes
266
Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
266